Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Charles River (CRL) to $200 from $190 and keeps an Outperform rating on the shares. The firm’s survey work points to a positive outlook for preclinical CROs, with rising budgets and declining cancellations, along with suggesting stable demand for discovery and toxicology services into 2025 and 2026, the analyst tells investors in a note on the group. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! U ...

Evercore ISI raised the firm’s price target on Labcorp (LH) to $305 from $300 and keeps an Outperform rating on the shares. The firm’s survey work points to a positive outlook for preclinical CROs, with rising budgets and declining cancellations, along with suggesting stable demand for discovery and toxicology services into 2025 and 2026, the analyst tells investors in a note on the group. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, ad ...

Piper Sandler analyst Paul Newsome lowered the firm’s price target on Arthur J. Gallagher (AJG) to $340 from $352 and keeps an Overweight rating on the shares. The firm is adjusting the mechanics of its model that was double-counting acquisition earnout payables in the brokerage segment. Piper is also adjusting the mechanics of its assumptions for the acquisition of Woodruff Sawyer. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced ...

Piper Sandler lowered the firm’s price target on Bowhead Specialty (BOW) to $33 from $38 and keeps an Overweight rating on the shares. The firm is also lowering its GWP growth estimates in the back half of 2025 as Piper thinks growth was more heavily weighted in the first half of the year. Softening market conditions will likely make it harder to achieve growth as high as it was in the first half of the year. The firm is also expecting loss ratios to look more similar to the first half of the year. Elevat ...

RBC Capital lowered the firm’s price target on Freeport-McMoRan (FCX) to $48 from $54 and keeps a Sector Perform rating on the shares. The firm is reducing its FY25 EPS view to $1.24 from $1.52 and its FY26 view to $1.38 from $2.02 following updated guidance from Freeport last week the company provided an update on the Grasberg incident. A lot of the downside risk could be reflected in the shares currently, but there is still uncertainty around the path forward at the site, the analyst tells investors in a ...

Evercore ISI analyst John Pancari raised the firm’s price target on First Horizon (FHN) to $26 from $25 and keeps an Outperform rating on the shares. Regional bank and specialty finance trends “appear solid” for Q3, but full momentum in earnings might not be seen until early 2026, the analyst tells investors in a preview for the group. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you in ...

BofA raised the firm’s price target on Hasbro (HAS) to $100 from $95 and keeps a Buy rating on the shares after having hosted an investor field trip to Atlanta MagicCon including meetings with CEO Chris Cocks and other executives. Following the meetings, the firm believes Magic can comp a very strong 2025 given the strength of its 2026 set schedule and believes Hasbro has a robust video game pipeline, the analyst tells investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% ...

Benchmark analyst Matthew Harrigan raised the firm’s price target on Live Nation (LYV) to $190 from $180 and keeps a Buy rating on the shares, but notes that the firm is “more significantly deferring realization into 2026” for its increased target given the “Washington regulatory cloud” that persists with further FTC action this month via a lawsuit. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...

价格目标调整 - Raymond James将Range Resources目标价从45美元下调至41美元 但维持优于大盘评级 [1] - 公司认为若强劲天然气前景在未来几年实现 该股存在更大上行潜力 [1] 投资前景 - 分析师通过研究报告向投资者传达对天然气行业的积极展望 [1] - 天然气行业未来几年可能呈现强劲发展态势 [1]

目标价调整 - Lake Street分析师Ben Klieve将Bioceres目标价从8美元下调至5美元 同时维持买入评级 [1] 财务表现 - 第四季度业绩显著低于所有细分市场预期 [1] - 2025财年预计将成为EBITDA低谷期 [1] 产品价值 - 公司下一代产品组合具有潜在价值 [1]